var

2 tekniker jobb hittade för dig i västra götalands län.

filtrering4
filtrering:
1plats
jobbtyp
3yrkesområde
alla filter
valda filter:
forskning
kemister & kemitekniker
tekniker
västra götalands län
rensa sökning
valda filter:
forskning
kemister & kemitekniker
tekniker
västra götalands län
rensa sökning
    • göteborg, västra götalands län
    • konsultuppdrag
    We at Randstad Life Sciences are currently looking for medical technologies professionals in the field of life science for future full-time consultant positions.Randstad Life Sciences is specialized in competences within Life Science. As a consultant you get a competitive salary, benefits and collective agreements. Your consultant manager ensures that you get varying and developing assignments at different companies, within different industries. At
    We at Randstad Life Sciences are currently looking for medical technologies professionals in the field of life science for future full-time consultant positions.Randstad Life Sciences is specialized in competences within Life Science. As a consultant you get a competitive salary, benefits and collective agreements. Your consultant manager ensures that you get varying and developing assignments at different companies, within different industries. At
    • göteborg, västra götalands län
    • konsultuppdrag
    Are you an ADME specialist and DMPK project team lead? We are now looking for a new team member for our client IRLAB Therapeutics AB in Gothenburg. IRLAB Therapeutics is a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most troublesome symptoms of Parkinson’s disease. Their drug portfolio comprises two Phase IIb drug candidates, two preclinical candidates preparing for Phase I studies, and a well-advanced
    Are you an ADME specialist and DMPK project team lead? We are now looking for a new team member for our client IRLAB Therapeutics AB in Gothenburg. IRLAB Therapeutics is a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most troublesome symptoms of Parkinson’s disease. Their drug portfolio comprises two Phase IIb drug candidates, two preclinical candidates preparing for Phase I studies, and a well-advanced